Monsuller, Eusebio .
HRN: 28-26-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2025
CEFUROXIME 750MG (VIAL)
12/12/2025
12/18/2025
IV
480mg
Q8
PCAP B, UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes